About 900 reports
Global Gastrointestinal Drug Market to 2022 - Pipeline Characterized by Emerging Biologic Therapies, While TNF Inhibitors and PPIs Continue to Dominate Therapy Landscape
- GASTROINTESTINAL THERAPEUTICS MARKET, GLOBAL, CLINICAL PROGRAM SIZE BY
- GASTROINTESTINAL THERAPEUTICS MARKET, GLOBAL, CLINICAL TRIAL DURATION BY
The MTD was not reached during this phase of the trial, and the majority of adverse events were mild or moderate gastrointestinal or hematological toxicities.
Global Dermatology Drugs Market to 2023 - Growth Driven by Increased Uptake of Interleukin Receptor Inhibitors for Psoriasis and Atopic Dermatitis
Minor AEs such as stomatitis, headaches, fatigue and gastrointestinal problems such as nausea and vomiting may occur when using Metolate.
Global Immunology Drugs Market to 2022 - Increasing Prevalence, Repositioning Opportunities and Strong Uptake of Interleukin Receptor Inhibitors to Drive Growth
- Pipeline Landscape Assessment
Gastrointestinal Cancer Research; ##(##): ##-## Mayo Clinic (2014).
Global Pain Therapeutics Market to 2023 - Innovative New Products to Address Unmet Need within Chronic Pain and Migraine, and Tackle Opioid Abuse
As such, non-selective COX inhibitors typically produce COX-## inhibitory gastrointestinal (GI) side effects, including gastric ulceration, bleeding and perforation.
- Pharmaceutical Industry, Clinical Trial Failure Rates in Phase I by Therapy Area,
- Pharmaceutical Industry, Clinical Trial Duration in Phase II by Therapy Area, 2006-
Phase I failure rates ranged broadly from ##% in immunology and ##% in gastrointestinal disorders to ##% in musculoskeletal disorders.
Global Neurodegenerative Drugs Market to 2022 - Growth Driven by an Aging Population, the Approval of Novel Immunomodulators and Neuromodulators, and Strong Uptake of Marketed Anti-Inflammatory Treatments
This method avoids the gastrointestinal tract and leads to more rapid effects, compared to orally administered levodopa.
Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19
Dietary factors have a substantial influence on the risk of cancers of the gastrointestinal tract.
Global Cancer Supportive Care Therapeutics Market to 2022 - Patent Expirations Create Opportunities for Biosimilars in the Chemotherapy Induced Anemia and Neutropenia Markets
When gastrointestinal AEs were reported their intensity was much lower than with oxycodone.
Global Diabetes and Obesity Drugs Market to 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment
As previously outlined, Xenical is a gastrointestinal lipase inhibitor that acts specifically in the lumen of the stomach and small intestine.
Global Respiratory Drugs Market to 2023 - A Changing Therapeutic Landscape as Key Patents Expire and Biologics, Targeted Therapies and CFTR Modulators for Asthma and Cystic Fibrosis Treatment Emerge as Market Growth Drivers
AS CF IS A MULTI-SYSTEM DISEASE, EVEN IF THE LUNG TRANSPLANT IS SUCCESSFUL, PANCREATIC, GASTROINTESTINAL AND REPRODUCTIVE PROBLEMS WILL REMAIN.
Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market
Gastrointestinal Cancer Research; ##(##): ##-## Hurwitz H, et al. (2004).
Global Hematological Cancers Market to 2022 - Commercially Successful Targeted Therapies and Large, Innovative Pipeline to Drive Market
It is also in development within the gastrointestinal disease area.
Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of Targeted Therapies, with Asthma and Cystic Fibrosis Leading the Way
As CF is a multi-system disease, even if the lung transplant is successful, pancreatic, gastrointestinal and reproductive problems will remain.
Global Non-Hematological Cancers Market to 2021 - Strong growth driven by increased uptake of low toxicity targeted treatments and versatile biologics
In contrast, Tykerb (lapatinib), which also targets HER##, has a very low associated incidence of cardiac AEs and is instead more frequently associated with skin and gastrointestinal events.
Global Dermatology Market to 2022 - Innovative Pipeline and Increasing Uptake of Biologics to Diversify Treatment Options and Drive Strong Growth
Minor AEs such as stomatitis, headaches, fatigue and gastrointestinal problems such as nausea and vomiting may occur when using methotrexate.
Osteoporosis Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Anabolic Therapies
All treatment regimens were well tolerated, with a similar incidence of upper gastrointestinal (GI) AEs.
Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market
Patients may develop gastrointestinal perforations, in which case treatment is stopped immediately.
Global Cardiovascular Disease Market to 2022 - Sanofi and Novartis to Become Market Leaders as Praluent and Entresto Drive Revenue Growth
Heparin is given intravenously due to poor gastrointestinal tract absorbability.
Global Antibacterial Drugs Market to 2022 - Vaccines Retain Market Prominence While Pipeline Offers Innovative Approaches to Tackling Antimicrobial Resistance
FIGURE ##: ANTIBACTERIAL DRUG MARKET, GLOBAL, OVERALL PHARMACEUTICAL INDUSTRY PIPELINE BY Metabolicdisorders Oncology Immunology Infectiousdisease Centralnervoussystem Respiratory Cardiovascular Ophthalmology Gastrointestinal Bacterialinfections Dermatology Geneticdisorders Musculoskeletald
Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2022 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth
Gastrointestinal events such as nausea and diarrhea occurred most frequently.
Rheumatoid Arthritis Therapeutics in South-East Asia Markets to 2022 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs
Biologics are susceptible to metabolism in the gastrointestinal tract and lack permeability, which collectively leads to poor bioavailability.
Global Urological Cancer Market to 2022 - Strong Growth Driven by Rising Prevalence, Increased Uptake of Hormone Therapies and Approval of Novel Biologics
Advances in the treatment of gastrointestinal stromal tumours.
Humanized Mouse Model Market by Type, Application & End User(Pharmaceutical & Biotech Companies, CRO - Global Forecast to 2021
NOD (DRAG) mice sustain the Complex Vertebrate Life Cycle of Plasmodium Falciparum Malaria Complex Interactions Among Diet, Gastrointestinal Transit, and Gut Microbiota in Humanized Mice Model of Ischemic Stroke Potential Limitations of the NSG Humanized Mouse as a Model System to Optimize
- Clinical Trials by E7 Countries: Proportion of Functional (Non Ulcer) Dyspepsia to Gastrointestinal...
- Clinical Trials by G7 Countries: Proportion of Functional (Non Ulcer) Dyspepsia to Gastrointestinal...
Gastric Cancer Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Prevalence and Launch of Targeted Therapies
Gastrointestinal Endoscopy; ##(##): ##-## Chung HC, et al. (2016).
PharmaPoint: HER2-Negative/HR+ and Triple Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2025
However, because the drug is associated with severe adverse reactions, it carries a boxed warning for gastrointestinal (GI) perforations, surgery, wound-healing complications, and hemorrhage.
- Proportion of Eosinophilic Esophagitis to Gastrointestinal Clinical Trials, G7 Countries...
- Clinical Trials by G7 Countries: Proportion of Eosinophilic Esophagitis to Gastrointestinal...
Type 2 Diabetes Mellitus Therapeutics in Asia-Pacific Markets to 2021 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth
Gastrointestinal events such as nausea and diarrhea occurred most frequently.